Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Ullrich

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 13, 2018
The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy DietStefan Z Lutz, Anita M Hennige, Andreas Peter, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2015
Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetesLaura Simon-Szabó, Márton Kokas, Zoltán Greff, et al.
Cancer Research|February 7, 2002
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) alleleJohannes Bange, Dieter Prechtl, Yuri Cheburkin, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 7, 2012
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesisEnza Piccolo, Nicola Tinari, Daniela Semeraro, et al.
Scientific Reports|May 19, 2018
Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in HumansStefan Z Lutz, Mathias Falcenberg, Fausto Machicao, et al.
Cancer Cell|May 6, 2008
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancerNikolas H Stoecklein, Stefan B Hosch, Martin Bezler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
ErbB-3 predicts survival in ovarian cancerBerno Tanner, Dirk Hasenclever, Katja Stern, et al.
Molecular Cancer|January 28, 2014
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancerDaniel S W Tan, Benjamin Haaland, Jia Min Gan, et al.
Assay and Drug Development Technologies|November 25, 2005
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technologyGyörgy Kéri, Zsolt Székelyhidi, Péter Bánhegyi, et al.
Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Endocrinology and Metabolism|December 13, 2018
The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy DietStefan Z Lutz, Anita M Hennige, Andreas Peter, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2015
Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetesLaura Simon-Szabó, Márton Kokas, Zoltán Greff, et al.
Cancer Research|February 7, 2002
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) alleleJohannes Bange, Dieter Prechtl, Yuri Cheburkin, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 7, 2012
LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesisEnza Piccolo, Nicola Tinari, Daniela Semeraro, et al.
Scientific Reports|May 19, 2018
Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in HumansStefan Z Lutz, Mathias Falcenberg, Fausto Machicao, et al.
Cancer Cell|May 6, 2008
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancerNikolas H Stoecklein, Stefan B Hosch, Martin Bezler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2006
ErbB-3 predicts survival in ovarian cancerBerno Tanner, Dirk Hasenclever, Katja Stern, et al.
Molecular Cancer|January 28, 2014
Bosutinib inhibits migration and invasion via ACK1 in KRAS mutant non-small cell lung cancerDaniel S W Tan, Benjamin Haaland, Jia Min Gan, et al.
Assay and Drug Development Technologies|November 25, 2005
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technologyGyörgy Kéri, Zsolt Székelyhidi, Péter Bánhegyi, et al.
Nature|February 21, 2014
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cellsMagdalena Paolino, Axel Choidas, Stephanie Wallner, et al.
Pageof 13